| P2093 | author name string | Horng-Rong Chang | |
| | Shun-Fa Yang | |
| | Jen-Pi Tsai | |
| | Yi-Hsien Hsieh | |
| | Hui-Ling Chiou | |
| | Chia-Liang Lin | |
| | Min-Hong Hsieh | |
| P2860 | cites work | Licochalcone A inhibits the invasive potential of human glioma cells by targeting the MEK/ERK and ADAM9 signaling pathways | Q93348122 |
| | Oxidative stress induces ADAM9 protein expression in human prostate cancer cells | Q24305515 |
| | Cancer statistics, 2013 | Q27860762 |
| | Expression of ADAM-9 mRNA and protein in human breast cancer | Q28206466 |
| | A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions | Q28254145 |
| | Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway | Q28386841 |
| | ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression | Q33346972 |
| | IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion | Q33612349 |
| | Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. | Q33960065 |
| | Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells | Q33986266 |
| | Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis | Q34320916 |
| | Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S | Q34599128 |
| | Apoptosis by dietary agents for prevention and treatment of prostate cancer | Q34614042 |
| | Flavonoids: Promising anticancer agents | Q35112798 |
| | The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study | Q35623073 |
| | Dietary flavonoids: effects on xenobiotic and carcinogen metabolism | Q36313653 |
| | Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients | Q36619772 |
| | Fisetin inhibits growth, induces G₂ /M arrest and apoptosis of human epidermoid carcinoma A431 cells: role of mitochondrial membrane potential disruption and consequent caspases activation | Q37051658 |
| | Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. | Q37671681 |
| | Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways | Q37715063 |
| | Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012. | Q38057087 |
| | International variations and trends in renal cell carcinoma incidence and mortality. | Q38275510 |
| | The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma | Q38769269 |
| | Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2. | Q38926832 |
| | Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway | Q38941759 |
| | Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling | Q39011116 |
| | Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells | Q39635235 |
| | Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549. | Q39804651 |
| | Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells | Q40345970 |
| | The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsin B activity | Q40538936 |
| | YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin | Q40720588 |
| | Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway | Q42726405 |
| | Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. | Q43736429 |
| | 16-Hydroxycleroda-3, 13-dien-15, 16-olide inhibits the proliferation and induces mitochondrial-dependent apoptosis through Akt, mTOR, and MEK-ERK pathways in human renal carcinoma cells | Q46257765 |
| | Fisetin Induces Apoptosis Through p53-Mediated Up-Regulation of DR5 Expression in Human Renal Carcinoma Caki Cells. | Q46327293 |
| | Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway | Q46606929 |
| | Hispolon suppresses metastasis via autophagic degradation of cathepsin S in cervical cancer cells. | Q47100235 |
| | Alpha-Mangostin Suppresses the Metastasis of Human Renal Carcinoma Cells by Targeting MEK/ERK Expression and MMP-9 Transcription Activity | Q47346980 |
| | Galangin increases ERK1/2 phosphorylation to decrease ADAM9 expression and prevents invasion in A172 glioma cells | Q47426288 |
| | Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models. | Q48360649 |
| | Sulforaphane suppresses oral cancer cell migration by regulating cathepsin S expression. | Q54113625 |
| | Lysosomal cathepsin B: correlation with metastatic potential | Q70777196 |
| | Critical function for ADAM9 in mouse prostate cancer | Q81362568 |
| | The origin, evolution and route to metastasis of clear cell RCC | Q89014735 |
| | Timosaponin AIII inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT/miR-129-5p axis | Q90861562 |
| | Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway | Q90948102 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P921 | main subject | fisetin | Q418384 |
| | renal cell carcinoma | Q1164529 |
| P577 | publication date | 2019-08-21 | |
| P1433 | published in | Cells | Q27724621 |
| P1476 | title | Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9 | |
| P478 | volume | 8 | |